fezolinetant
fezolinetant is listed in the FDA National Drug Code directory with 3 NDC codes, marketed under brand name including VEOZAH. Available dosage form: tablet, film coated.
Drug Details
- Generic Name
- fezolinetant
- Brand Names
- VEOZAH
- Application Number
- NDA216578
- Sponsor
- Astellas Pharma US, Inc.
- NDC Codes
- 3
- Dosage Forms
- TABLET, FILM COATED
- Routes
- ORAL
- Active Ingredients
- FEZOLINETANT
Indications and Usage
1 INDICATIONS AND USAGE VEOZAH ® is indicated for the treatment of moderate to severe vasomotor symptoms due to menopause. VEOZAH is a neurokinin 3 (NK3) receptor antagonist indicated for the treatment of moderate to severe vasomotor symptoms due to menopause. ( 1 )